{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:41:11Z","timestamp":1763037671207,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.pathol.2021.10.001","type":"journal-article","created":{"date-parts":[[2021,11,23]],"date-time":"2021-11-23T01:03:29Z","timestamp":1637629409000},"page":"116-120","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting"],"prefix":"10.1016","volume":"54","author":[{"given":"Hemalatha","family":"Varadhan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vishal","family":"Ahuja","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Pitman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dominic E.","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"Xpert Xpress SARS-CoV-2: Instructions for Use.","key":"10.1016\/j.pathol.2021.10.001_bib1"},{"key":"10.1016\/j.pathol.2021.10.001_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/ofid\/ofaa387","article-title":"The antibody response to SARS-CoV-2 infection","volume":"7","author":"Hueston","year":"2020","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.pathol.2021.10.001_bib3","doi-asserted-by":"crossref","first-page":"104683","DOI":"10.1016\/j.jcv.2020.104683","article-title":"A\u00a0needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay","volume":"133","author":"Khoshchehreh","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.pathol.2021.10.001_bib4","doi-asserted-by":"crossref","first-page":"104660","DOI":"10.1016\/j.jcv.2020.104660","article-title":"Detection of SARS-COV N2 gene: very low amounts of viral RNA or false positive?","volume":"133","author":"Falasca","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.pathol.2021.10.001_bib5","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1016\/j.chest.2020.07.061","article-title":"SARS CoV-2 detection from upper and lower respiratory tract specimens: diagnostic and infection control implications","volume":"158","author":"Murphy","year":"2020","journal-title":"Chest"},{"key":"10.1016\/j.pathol.2021.10.001_bib6","doi-asserted-by":"crossref","first-page":"104578","DOI":"10.1016\/j.jcv.2020.104578","article-title":"Comparison of the analytical sensitivity of seven commonly used commercial SARS-CoV-2 automated molecular assays","volume":"130","author":"Mostafa","year":"2020","journal-title":"J\u00a0Clin Virol"},{"key":"10.1016\/j.pathol.2021.10.001_bib7","doi-asserted-by":"crossref","first-page":"e1457","DOI":"10.1016\/S2214-109X(20)30428-9","article-title":"GeneXpert for the diagnosis of COVID-19 in LMICs","volume":"8","author":"Rakotosamimanana","year":"2020","journal-title":"Lancet Glob Health"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521005286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302521005286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:27:37Z","timestamp":1758472057000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302521005286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S0031302521005286"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2021.10.001","relation":{},"ISSN":["0031-3025"],"issn-type":[{"type":"print","value":"0031-3025"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Weak positive SARS-CoV-2 N2 gene results using the Xpress Xpert assay: the need for an alternate interpretative criteria in a low prevalence setting","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2021.10.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier B.V. on behalf of Royal College of Pathologists of Australasia. All rights reserved.","name":"copyright","label":"Copyright"}]}}